Correlation Between Amplia Therapeutics and BiOasis Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amplia Therapeutics and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amplia Therapeutics and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amplia Therapeutics Limited and biOasis Technologies, you can compare the effects of market volatilities on Amplia Therapeutics and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amplia Therapeutics with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amplia Therapeutics and BiOasis Technologies.

Diversification Opportunities for Amplia Therapeutics and BiOasis Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Amplia and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Amplia Therapeutics Limited and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Amplia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amplia Therapeutics Limited are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Amplia Therapeutics i.e., Amplia Therapeutics and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Amplia Therapeutics and BiOasis Technologies

If you would invest  8.20  in Amplia Therapeutics Limited on August 27, 2024 and sell it today you would lose (2.30) from holding Amplia Therapeutics Limited or give up 28.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amplia Therapeutics Limited  vs.  biOasis Technologies

 Performance 
       Timeline  
Amplia Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Amplia Therapeutics Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile primary indicators, Amplia Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Amplia Therapeutics and BiOasis Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amplia Therapeutics and BiOasis Technologies

The main advantage of trading using opposite Amplia Therapeutics and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amplia Therapeutics position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.
The idea behind Amplia Therapeutics Limited and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments